American International Group, Inc. Brainstorm Cell Therapeutics Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.01 - $4.01 $53,505 - $71,281	-17,776 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.46 - $7.88 $7,366 - $16,776	2,129 Added 13.61%	17,776 $68,000
Q4 2020 Feb 12, 2021	SELL	$3.99 - $17.73 $5,709 - $25,371	-1,431 Reduced 8.38%	15,647 $71,000
Q3 2020 Nov 04, 2020	BUY	$11.19 - $16.92 $8,593 - $12,994	768 Added 4.71%	17,078 $289,000
Q2 2020 Aug 12, 2020	BUY	$4.42 - $12.66 $72,090 - $206,484	16,310 New	16,310 $183,000

549K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $56.9M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.